PACTR201101000273931Other未知
Isoniazid or Rifampicin and Isoniazid Preventive Therapy for children exposed to TB - the IRIPT trial
Christian Wejse0 个研究点目标入组 880 人开始时间: 2011年1月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- 入组人数
- 880
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 Year(s) 至 15 Year(s)（—）
- 性别
- All
入选标准
- •1)Household contact of TB case
- •2)Age<5 years or
- •age 5-14 years + a positive TST (>5mm)
- •3)Informed consent given by parent or person in loco parentis
排除标准
- •1)Active TB at time of inclusion
- •2)HIV-positive child receiving HAART
- •3)Known liver disease or allergy to INH or RIF
- •4)Pregnancy (all girls>12 years will get a pregnancy test)
- •5)A history of seizures
研究者
相似试验
已完成
4 期
Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment InitiationTuberculosisNCT02231229Assistance Publique - Hôpitaux de Paris204
尚未招募
不适用
CHILDHOOD PULMONARY TUBERCULOSIS CASES SHOWING RESISTANCE TO ISONIAZID BUT SENSITIVE TO RIFAMPICIN BY CBNAATCTRI/2021/03/032203MAULANA AZAD MEDICAL COLLEGE AND LOK NAYAK HOSPITALNEW DELHI
招募中
不适用
'The effect of two treatment regimens: weekly rifapentine and isoniazid (3HP), compared to 4 months of daily rifampicin (4RIF) on adherence to treatment for latent tuberculosisACTRN12618001672246Royal Prince Alfred Hospital, Sydney Local Health District210
尚未招募
4 期
Pharmacokinetics of rifapentine and isoniazid and NAT2 and SLCO1B1 polymorphisms in pediatric Thai patients with latent tuberculosis infectioPediatric Thai patients with latent tuberculosis infectionrifapentine,isoniazid,pharmacokinetics,pediatric,latent tuberculosis infectionTCTR20190423002submitted proposal for HSRI funding of tuberculosis25
已完成
不适用
The role of isoniazid medication in preventing progression to active tuberculosis disease in persons with latent tuberculosis: The effect on the body’s immune systematent tuberculosis infectionInfections and InfestationsTuberculosisISRCTN15705625College of Health Sciences, Makerere University145